首页/数据集/Comparison between treatments vs. corresponding Control values at CSR/END midpoint.

Comparison between treatments vs. corresponding Control values at CSR/END midpoint.

NIAID Data Ecosystem2026-03-10 收录

数据链接：

https://figshare.com/articles/dataset/Comparison_between_treatments_vs_corresponding_Control_values_at_CSR_END_midpoint_/5141497 数据链接链接失效反馈

官方服务：

资源简介：

Comparison between treatments vs. corresponding Control values at CSR/END midpoint.

应用场景：

创建时间：

2017-06-24

临床试验终点分析

敏感性分析

an = Day 3 PP population minus six patients (two adults, four children) with ‘poor model fit’ due to the model being inadequate to fit their data. P values that are statistically significant are in it

NIAID Data Ecosystem50

Results for the primary endpoint – effects on the hospitalization rate in the ITT and R-PP-CC population.

临床试验终点分析

住院率疗效评估

Results for the primary endpoint – effects on the hospitalization rate in the ITT and R-PP-CC population.

Figshare2025-05-15 更新30

The patients amount with different numbers of chronic pulmonary disease exacerbations for 24±1 weeks (FAS and PP populations).

慢阻肺急性加重

临床试验终点分析

The patients amount with different numbers of chronic pulmonary disease exacerbations for 24±1 weeks (FAS and PP populations).

Figshare2021-12-23 更新10

PFS and OS analysis with Kaplan-Meier method and log-rank test.

肿瘤生存分析

临床试验终点分析

*Factors at p<0.1 level enter into Cox regression analysis. P-values for further analysis (p<0.1) are in bold. **95% CI cannot be calculated as 3 out of 5 individuals in the subgroup are censored. ***

NIAID Data Ecosystem40

Summary statistics for safety and efficacy endpoints for both the modified safety and per-protocol (PP) populations.

临床试验终点分析

药物安全性评估

Summary statistics for safety and efficacy endpoints for both the modified safety and per-protocol (PP) populations.

NIAID Data Ecosystem10